The George Washington University Hospital is a for-profit hospital, located in Washington, D.C. in the United States. It is affiliated with the George Washington University School of Medicine and Health Sciences.

There are 371 beds in George Washington University Medical Center.

During the past decade, George Washington University Medical Center conducted 51 clinical trials. In the 10-year time frame, 51 clinical trials started and 33 clinical trials were completed, i.e. on average, 64.7% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 11 clinical trials were completed. i.e. 64.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "George Washington University Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 23 trials, followed by "National Institute of Allergy and Infectious Diseases (NIAID)" with 19 trials sponsored, "George Washington University" with 17 trials sponsored, "Gilead Sciences" with 7 trials sponsored and "Pfizer" with 7 trials sponsored. Other sponsors include 113 different institutions and companies that sponsored additional 91 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "George Washington University Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 20 trials as a collaborator, "Bristol-Myers Squibb" with 6 trials as a collaborator, "Canadian Cancer Trials Group" with 5 trials as a collaborator, "Cancer and Leukemia Group B" with 4 trials as a collaborator and "Glaxo Wellcome" with 3 trials as a collaborator. Other collaborators include 65 different institutions and companies that were collaborators in the rest 63 trials.

According to Clinical.Site data, the most researched conditions in "George Washington University Medical Center" are "HIV Infections" (52 trials), "Breast Cancer" (4 trials), "Meningitis, Cryptococcal" (4 trials), "Colorectal Cancer" (3 trials) and "HIV Infection" (3 trials). Many other conditions were trialed in "George Washington University Medical Center" in a lesser frequency.

Most popular intervention types in "George Washington University Medical Center" are "Drug" (127 trials), "Other" (37 trials), "Device" (22 trials), "Procedure" (22 trials) and "Biological" (21 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (17 trials), "Quality-of-Life Assessment" (14 trials), "Zidovudine" (14 trials), "Laboratory Biomarker Analysis" (12 trials) and "Questionnaire Administration" (9 trials). Other intervention names were less common.

The vast majority of trials in "George Washington University Medical Center" are 161 trials for "All" genders, 17 trials for "Female" genders and 13 trials for "Male" genders.

Currently, there are NaN active trials in "George Washington University Medical Center". undefined are not yet recruiting, 24 are recruiting, 24 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 131 completed trials in George Washington University Medical Center, 1 suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in George Washington University Medical Center, 11 "Phase 1" clinical trials were conducted, 46 "Phase 2" clinical trials and 73 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 11 trials, and there were also 36 trials that are defined as “Not Applicable".

George Washington University Medical Center has several departments that took part in Clinical trials: "The George Washington University- Department of Otolaryngology" - 2 trials, "Department of Rheumatology" - 2 trials